Drug Profile
Ketoprofen topical
Alternative Names: EN 3269; KeofixLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Applied Pharma Research; Labtec
- Developer Zambon Company SpA
- Class Analgesics; Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
- Mechanism of Action Arachidonic acid inhibitors; Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 04 Aug 2008 ProEthic Pharmaceuticals has been acquired by Kowa
- 01 Nov 2007 Interim efficacy and adverse events data from a phase III trial in Pain released by Endo Pharmaceuticals
- 11 Jul 2006 Final results from two phase III clinical trials in patients with Inflammation have been added to the adverse events and Pain therapeutic trials sections ,